In silico and in vitro evaluation of nano-enhanced therapeutics for diabetes management (2025)
Sil, Moumita; Deb, Debanik; Dalui, Shauryabrota; Chakraborty, Subhajit; Goswami, Arunava; Polikarpov, Igor 
Source: Journal of Applied Pharmaceutical Science. Unidade: IFSC
Subjects: DIABETES MELLITUS, PLANEJAMENTO DE FÁRMACOS, NANOCIÊNCIA, NANOPARTÍCULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SIL, Moumita et al. In silico and in vitro evaluation of nano-enhanced therapeutics for diabetes management. Journal of Applied Pharmaceutical Science, v. 15, n. 7, p. 169-178, 2025Tradução . . Disponível em: https://doi.org/10.7324/JAPS.2025.2411476. Acesso em: 15 jul. 2025.APA
Sil, M., Deb, D., Dalui, S., Chakraborty, S., Goswami, A., & Polikarpov, I. (2025). In silico and in vitro evaluation of nano-enhanced therapeutics for diabetes management. Journal of Applied Pharmaceutical Science, 15( 7), 169-178. doi:10.7324/JAPS.2025.2411476NLM
Sil M, Deb D, Dalui S, Chakraborty S, Goswami A, Polikarpov I. In silico and in vitro evaluation of nano-enhanced therapeutics for diabetes management [Internet]. Journal of Applied Pharmaceutical Science. 2025 ; 15( 7): 169-178.[citado 2025 jul. 15 ] Available from: https://doi.org/10.7324/JAPS.2025.2411476Vancouver
Sil M, Deb D, Dalui S, Chakraborty S, Goswami A, Polikarpov I. In silico and in vitro evaluation of nano-enhanced therapeutics for diabetes management [Internet]. Journal of Applied Pharmaceutical Science. 2025 ; 15( 7): 169-178.[citado 2025 jul. 15 ] Available from: https://doi.org/10.7324/JAPS.2025.2411476
